Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01571713 · ClinicalTrials.gov registry record
Side Effects of Pulmonary Hypertension Medications
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 250
- Enrollment target
NCT01571713: Completed study, sponsored by Stanford University.
NCT01571713 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 250 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01571713 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
The study seeks to analyze the patient reported effects of pulmonary hypertension medications and compare these with the side effects described on the package inserts. Side effects for these PH medications have been described in the adult population, but have never been described in the pediatric population. This information can better improve patient care and be used to characterize the side effects resultant from these medications.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2011-08 |
| Est. Completion | 2020-12 |
What the finished NCT01571713 record still lists
NCT01571713 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01571713 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01571713 about?
NCT01571713 is a clinical study titled "Side Effects of Pulmonary Hypertension Medications". The study seeks to analyze the patient reported effects of pulmonary hypertension medications and compare these with the side effects described on the package inserts. Side effects for these PH medications have been described in the adult population, but have never been described in the pediatric po...
What is the current status of trial NCT01571713?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2011-08. Estimated completion is 2020-12.
Who is sponsoring clinical trial NCT01571713?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia